Louisiana Board of Pharmacy posted Regulatory Proposal 2025-F to revise Controlled Dangerous Substances rules, including incorporating DEA regulations (21 CFR Parts 1300–1399) by reference

The Louisiana Board of Pharmacy has published a regulatory proposal package (Regulatory Proposal 2025-F) to amend its Controlled Dangerous Substances rules (Title 46, Part LIII, Chapter 27). The proposal described in the draft would reduce redundancy by incorporating federal DEA controlled substance regulations (21 CFR Parts 1300–1399) by reference and consolidating Louisiana-specific deviations into a specified section (e.g., §2713), with repeal/cleanup of redundant provisions. If adopted, controlled-substance registrants and pharmacies would need to align procedures and documentation to the updated LAC structure and the incorporated federal requirements as referenced by the Board rule.